Form 4: Saba Capital Management Reduces Stake in BlackRock Capital Allocation Term Trust

Saba Capital Management, a 10% owner and director, decreased its holdings in BlackRock Capital Allocation Term Trust (BCAT) through recent sales.

Summary

• Saba Capital Management, L.P., along with director Boaz Weinstein, reported changes in their beneficial ownership of BlackRock Capital Allocation Term Trust (BCAT) shares.
• On February 13, 2025, Saba Capital Management sold 116,265 shares of BCAT at a price of $15.86 per share.
• Following this transaction, Saba Capital Management indirectly held 12,843,341 shares.
• On February 14, 2025, Saba Capital Management sold an additional 58,394 shares at $15.60 per share, resulting in indirect ownership of 12,784,947 shares.
• These transactions were reported on Form 4, filed with the Securities and Exchange Commission (SEC).

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative as a major shareholder is reducing their position. This could indicate a lack of confidence or a shift in investment strategy.

Negatives

• Saba Capital Management reduced its stake in BlackRock Capital Allocation Term Trust (BCAT).

Industry Context

This filing reflects changes in ownership by a significant shareholder in a publicly traded investment fund. Such transactions are common and are closely watched by investors for insights into the sentiment and strategies of major stakeholders.

Stakeholder Impact

• Shareholders may react to the news of Saba Capital Management reducing its stake in BCAT.

Key Dates

Keywords

BlackRock Capital Allocation Term Trust, BCAT, Saba Capital Management, Boaz Weinstein, Beneficial Ownership, Form 4, SEC, Shares, Sale